The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2019

Filed:

Apr. 28, 2015
Applicant:

Medicinal Chemistry Pharmaceuticals, Co., Ltd., Hokkaido, JP;

Inventors:

Shinichiro Nishimura, Hokkaido, JP;

Risho Miyoshi, Hokkaido, JP;

Kentaro Naruchi, Hokkaido, JP;

Masakazu Tanaka, Hokkaido, JP;

Masaharu Sato, Hokkaido, JP;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01); C07K 16/28 (2006.01); C12Q 1/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3092 (2013.01); C07K 16/2896 (2013.01); G01N 33/574 (2013.01); G01N 33/57492 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C12Q 1/02 (2013.01); G01N 2333/70596 (2013.01); G01N 2400/02 (2013.01);
Abstract

The present invention provides: an antibody exhibiting specificity for MUC1, the antibody having a glycan structure expressed at high levels in cancer cells; a method for manufacturing this antibody; and a novel means and method for the diagnosis and prevention and/or treatment of cancer using this antibody. The present invention is a monoclonal antibody to human MUC1, wherein the antibody specifically recognizes a glycopeptide having a human MUC1 tandem unit and furthermore having an O-linked glycan core (0(Tn)) in any one of the threonine and serine in the amino acid sequence of this human MUC1 tandem unit. A method for detecting MUC1 in a human body-fluid sample. A kit including this monoclonal antibody. A pharmacological composition for the prevention and/or treatment of a malignant tumor, the pharmacological composition containing this monoclonal antibody as an active ingredient.


Find Patent Forward Citations

Loading…